首页|期刊导航|中国药理学与毒理学杂志|环鸟苷酸-腺苷酸合酶抑制剂RU.521通过调控JAK1/STAT3信号通路抑制类风湿关节炎巨噬细胞极化

环鸟苷酸-腺苷酸合酶抑制剂RU.521通过调控JAK1/STAT3信号通路抑制类风湿关节炎巨噬细胞极化OA

Cyclic GMP-AMP synthase inhibitor RU.521 inhibits macrophage polar-ization in rheumatoid arthritis through JAK1/STAT3 signaling pathway

中文摘要英文摘要

目的 探讨环鸟苷酸-腺苷酸合酶(cGAS)抑制剂RU.521对脂多糖(LPS)诱导的RAW264.7巨噬细胞极化和胶原诱导性关节炎(CIA)小鼠的影响及机制.方法 ① 细胞实验:将RAW264.7细胞分为细胞对照组、LPS组、LPS+RU.521 0.75、1.5、3.0 μmol·L-1组和LPS+托法替尼100 nmol·L-1组.除对照组外,其余各组均加入LPS 100 μg·L-1刺激,并同时给予相应药物处理24 h.Western印迹法测定细胞cGAS水平,以筛选RU.521显著抑制LPS诱导cGAS表达的浓度.实时定量qPCR检测细胞胞质mtDNA水平和cGAS mRNA表达;流式细胞术和免疫荧光检测活性氧(ROS)水平及线粒体膜电位;免疫荧光检测分化簇86(CD86)表达;RT-qPCR检测诱导型一氧化氮合酶(iNOS)、白细胞介素6(IL-6)、肿瘤坏死因子α(TNF-α)mRNA水平;流式细胞术分析M1/M2型巨噬细胞比值以评估巨噬细胞表型;Western印迹法检测cGAS、iNOS、精氨酸酶1(Arg-1)、PTEN诱导激酶1(PINK1)、泛素结合蛋白(p62)、E3泛素连接酶(Parkin)及微管相关蛋白1A/1B-轻链3(LC3)等自噬相关蛋白,以及Janus激酶1(JAK1)/信号转导及转录激活因子3(STAT3)通路相关蛋白的表达.② 动物实验:将小鼠分为正常对照组、模型组、模型+RU.521组和模型+托法替尼组.除正常对照组外,其余组于第0和21天尾根及背部皮内注射鸡Ⅱ型胶原与完全弗氏佐剂的乳剂.第28天以模型组平均关节炎评分显著高于正常对照组为造模成功.自第29天起,模型+RU.521组每2dip给予RU.521 5 mg·kg-1,模型+托法替尼组每日ig给予托法替尼10 mg·kg-1,持续4周.定期监测小鼠关节炎评分、足爪肿胀及体重;第66天取关节组织行HE染色观察膝关节组织病理学变化,并分离腹腔巨噬细胞,RT-qPCR检测cGAS、TNF-α和IL-6 mRNA表达;流式细胞术分析M1型巨噬细胞比例;Western印迹法检测 JAK1/STAT3蛋白磷酸化水平.结果 ① 细胞实验:与细胞对照组相比,LPS组胞质mtDNA水平、cGAS mRNA 表达水平和 ROS 水平升高,线粒体膜电位降低;CD86、iNOS 及iNOS、IL-6、TNF-α mRNA 表达升高,Arg-1表达降低,M1/M2比例升高;cGAS、Parkin、PINK1及p62表达上调,LC3-Ⅱ/LC3-Ⅰ比值降低,JAK1/STAT3通路被激活.与LPS组相比,RU.521抑制cGAS表达,降低ROS水平,恢复线粒体膜电位,下调CD86、iNOS、IL-6和TNF-α表达,上调Arg-1,降低M1/M2,抑制cGAS及PINK1、p62、Parkin表达,恢复LC3-Ⅱ/LC3-Ⅰ比值,并抑制JAK1和STAT3磷酸化激活.② 动物实验:与正常对照组比较,模型组小鼠膝关节炎评分显著升高,腹腔巨噬细胞cGAS、TNF-α和IL-6 mRNA表达水平显著升高、M1型细胞比例显著增加,JAK1/STAT3磷酸化水平显著升高;与模型组比较,RU.521可减轻膝关节损伤,降低腹腔巨噬细胞中cGAS、TNF-α和IL-6 mRNA表达水平及M1型细胞比例,并抑制JAK1/STAT3通路磷酸化.结论 RU.521通过调控JAK1/STAT3信号通路,抑制巨噬细胞M1型极化,缓解小鼠CIA.

OBJECTIVE To investigate the effect of cyclic GMP-AMP synthase(cGAS)inhibitor RU.521 on lipopolysaccharide(LPS)induced RAW264.7 macrophage polarization and collagen-induced arthritis(CIA)in mice and the molecular mechanism.METHODS ① Cell experiments:RAW264.7 cells were divided into a cell control group,LPS group,LPS+RU.521 0.75,1.5,and 3.0 μmol·L-1 groups,and LPS 100 ng·L-1 with tofacitinib 100 nmol·L-1 group.Except the control group,all these groups were stimulated with LPS 100 ng·L-1 and simultaneously treated with corresponding drugs for 24 h.Western blot was used to measure cellular cGAS levels,and the concentration of RU.521 that significantly inhibited LPS-induced cGAS expression was selected for subsequent mechanistic studies.Real-time quantitative PCR was used to measure cytoplasmic mtDNA levels and cGAS mRNA expres-sions.Flow cytometry and immunofluorescence were adopted to detect reactive oxygen species(ROS)levels and mitochondrial membrane potential.Cluster of differentiation 86(CD86)expressions were detected via immunofluorescence.RT-qPCR was employed to detect inducible nitric oxide synthase(iNOS),interleukin-6(IL-6),and tumor necrosis factor-α(TNF-α)mRNA levels.cGAS,iNOS,and argi-nase-1(Arg-1)protein expression levels were determined by Western blotting.The proportion of M1/M2 macrophages was calculated via flow cytometry to analyze the macrophage phenotype.Western blotting was used to detect cGAS,PTEN-induced kinase 1(PINK1),ubiquitin-binding protein(p62),E3 ubiquitin ligase(Parkin),and microtubule-associated protein 1A/1B-light chain 3(LC3),autophagy-related proteins,and Janus kinase 1(JAK1)/signal transducer and activator of transcription 3(STAT3)pathway-related protein expressions.② Animal experiments:Mice were divided into a normal control group,model group,model RU.521 group,and model tofacitinib group.Except the normal control group,these groups were intradermally injected at the root and back of tails with an emulsion of chicken typeⅡcollagen and complete Freund's adjuvant on days 0 and 21.On day 28,the model was considered successful when the average arthritis score of the model group was significantly higher than that of the normal control group.From day 29,the model RU.521 group received RU.521 at 5 mg·kg-1 intraperitoneally every 2 days while the model tofacitinib group received tofacitinib at 10 mg·kg-1 orally every day for 4 weeks.Arthritis scores,paw swelling,and body weight of the mice were monitored regularly.On day 66,joint tissues were collected for HE staining to observe pathological changes in the knee joint before peritoneal macrophages were isolated for RT-qPCR detection of cGAS,TNF-α,and IL-6 mRNA expressions.Flow cytometry was used to analyze the proportion of M1 macrophages while Western blotting was employed to detect the phosphorylation levels of JAK1/STAT3 proteins.RESULTS ① Cell experi-ments:Compared with the cell control group,cytoplasmic mtDNA levels,cGAS mRNA expressions and ROS levels were increased in the LPS group while mitochondrial membrane potential was decreased.CD86,iNOS,as well as iNOS,IL-6,TNF-α mRNA expressions were increased while the Arg-1 expres-sion was decreased.The M1/M2 ratio became higher,but expressions of cGAS,Parkin,PINK1 and p62 were upregulated.The LC3-Ⅱ/LC3-Ⅰratio was reduced,and the JAK1/STAT3 pathway was acti-vated.Compared with the LPS group,RU.521 inhibited cGAS expressions,reduced ROS levels,restored mitochondrial membrane potential,downregulated CD86,iNOS,IL-6,and TNF-α expressions,upregulated Arg-1,decreased the M1/M2 ratio,inhibited cGAS as well as PINK1,p62,and Parkin expressions,restored the LC3-Ⅱ/LC3-Ⅰratio,and suppressed the phosphorylation activation of JAK1 and STAT3.② Animal experiments:Compared with the normal control group,the mice in the model group showed significantly increased scores of knee arthritis,significantly elevated mRNA expression levels of cGAS,TNF-α,and IL-6 in peritoneal macrophages,a significantly increased proportion of M1-type cells,and significantly increased phosphorylation levels of JAK1/STAT3.Compared with the model group,RU.521 could alleviate knee joint damage,reduce the mRNA expression levels of cGAS,TNF-α and IL-6 in peritoneal macrophages and the proportion of M1-type cells while inhibiting phos-phorylation of the JAK1/STAT3 pathway.CONCLUSION RU.521 can inhibit macrophage M1 polariza-tion and alleviate CIA in mice by regulating JAK1/STAT3 signaling pathway,which is a potential treat-ment strategy for RA.

李梦雅;杨培培;徐修凤;方雪婷;张凤;疏金玲

安徽医科大学药学科学学院,安徽 合肥 230032||安徽医科大学第一附属医院药剂科,安徽 合肥 230022安徽医科大学第一附属医院药剂科,安徽 合肥 230022安徽医科大学药学科学学院,安徽 合肥 230032安徽医科大学药学科学学院,安徽 合肥 230032||安徽医科大学第一附属医院药剂科,安徽 合肥 230022安徽医科大学附属阜阳医院药剂科,安徽 阜阳 236000安徽医科大学药学科学学院,安徽 合肥 230032||安徽医科大学第一附属医院药剂科,安徽 合肥 230022

医药卫生

RU.521环鸟苷酸-腺苷酸合酶类风湿关节炎巨噬细胞自噬JAK1/STAT3

RU.521cyclic GMP-AMP synthaserheumatoid arthritismacrophageautophagyJAK1/STAT3

《中国药理学与毒理学杂志》 2026 (1)

53-66,14

安徽省高等学校科学研究项目(2022AH050780)抗炎免疫药物教育部重点实验室(安徽医科大学)开放课题(KFJJ-2020-07) Anhui Provincial Scientific Research Project of Higher Education Institutions(2022AH050780)and Open Project of the Key Laboratory of Anti-Inflammatory and Immunomodulatory Drugs of the Ministry of Education(Anhui Medical University)(KFJJ-2020-07)

10.3867/j.issn.1000-3002.2026.08721

评论